Nanostream Enters European Market with Opening of Sales and Support Office in The Netherlands

September 13, 2007
LCGC Staff

Nanostream, provider of products and services that increase productivity in laboratories at pharmaceutical and biotech companies, extends its global reach to Europe by establishing a sales and support office in The Netherlands.

Nanostream

, provider of products and services that increase productivity in laboratories at

pharmaceutical

and

biotech

companies, extends its global reach to Europe by establishing a sales and support office in The Netherlands. As part of the company's growth strategy in Europe, this new office will facilitate sales of Nanostream's micro parallel liquid chromatography products and assay development services to European scientists. Nanostream's sales effort and operations in Europe will be locally managed and supported by

Touchdown Biomarketing

.

"With global pharmaceutical companies deploying our products at multiple worldwide sites, it has become evident that we need a local presence in Europe to provide a higher level of service and support for these customers, " said Stephen Zolnay, VP of business development, Nanostream, Inc. "We are thrilled to provide a direct market presence for Nanostream in Europe, which will be critical for growth of our global install base."

"In the European market, we've seen a high demand for scientists investing in technology to improve productivity and data quality in early drug discovery," said Alan Chan, Business Development, Nanostream Europe. "Nanostream's technology allows scientists to develop assays, based on the physical separation of substrate and product, which are difficult or cannot be performed in a plate-based homogenous format. Working with Touchdown Biomarketing's experienced sales and support team and their broad network of European scientists, will enable us to be successful in accelerating the adoption of our technology in the life sciences market."

Nanostream products are employed in laboratories worldwide to reduce assay development time, increase throughput for analytical applications and overcome chromatography bottlenecks for drug metabolism studies. The company recently announced its new service offerings for assay development and other customized solutions for the screening laboratory.